126 related articles for article (PubMed ID: 22265853)
21. Selective and sequential transarterial chemoembolization: survival in patients with hepatocellular carcinoma.
Antoch G; Roelle G; Ladd SC; Kuehl H; Heusner TA; Sotiropoulos GC; Hilgard P; Forsting M; Verhagen R
Eur J Radiol; 2012 Sep; 81(9):2290-7. PubMed ID: 21978775
[TBL] [Abstract][Full Text] [Related]
22. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
24. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population.
Solomon B; Soulen MC; Baum RA; Haskal ZJ; Shlansky-Goldberg RD; Cope C
J Vasc Interv Radiol; 1999 Jun; 10(6):793-8. PubMed ID: 10392950
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
[TBL] [Abstract][Full Text] [Related]
26. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
28. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.
Vogl TJ; Langenbach MC; Hammerstingl R; Albrecht MH; Chatterjee AR; Gruber-Rouh T
Hepatol Int; 2021 Jun; 15(3):685-694. PubMed ID: 34043158
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of the Initial and Best Responses after Chemoembolization in the Treatment of Intermediate-Stage Hepatocellular Carcinoma with Preserved Liver Function.
Park C; Chu HH; Kim JH; Kim SY; Alrashidi I; Gwon DI; Yoon HK; Kim N
J Vasc Interv Radiol; 2020 Dec; 31(12):1998-2006.e1. PubMed ID: 32988715
[TBL] [Abstract][Full Text] [Related]
31. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
[TBL] [Abstract][Full Text] [Related]
32. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up.
Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF
J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
[TBL] [Abstract][Full Text] [Related]
34. Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Hammond JS; Franko J; Holloway SE; Heckman JT; Orons PD; Gamblin TC
Hepatogastroenterology; 2014; 61(133):1339-43. PubMed ID: 25436307
[TBL] [Abstract][Full Text] [Related]
35. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
36. Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.
Vogl TJ; Jost A; Nour-Eldin NA; Mack MG; Zangos S; Naguib NN
Br J Cancer; 2012 Mar; 106(7):1274-9. PubMed ID: 22382689
[TBL] [Abstract][Full Text] [Related]
37. [Transarterial chemoembolization in hepatocellular carcinomas: technique, indications, results].
Zangos S; Gille T; Eichler K; Engelmann K; Woitaschek D; Balzer JO; Mack MG; Thalhammer A; Vogl TJ
Radiologe; 2001 Oct; 41(10):906-14. PubMed ID: 11715582
[TBL] [Abstract][Full Text] [Related]
38. Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?
Georgiades C; Geschwind JF; Harrison N; Hines-Peralta A; Liapi E; Hong K; Wu Z; Kamel I; Frangakis C
Radiology; 2012 Oct; 265(1):115-23. PubMed ID: 22891361
[TBL] [Abstract][Full Text] [Related]
39. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
Inoue H; Miyazono N; Hori A; Kanetsuki I; Tanaka D; Fukukura Y; Tsuchimochi S; Hokotate H; Ida K; Ikeda K
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1049-53. PubMed ID: 8390227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
